Trial intelligence / Profile preview

Salvia officinalis for treatment of plaque psoriasis

IRCT20210202050214N1Phase 3Completed

Sponsor
Hormozgan University of Medical Sciences
Start
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of salvia officinalis in plaque psoriasis, sponsored by Hormozgan University of Medical Sciences. Started Apr 2021; status: completed.

02

Drugs

salvia officinalis
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on IRCT20210202050214N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210202050214N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call